Literature DB >> 22437823

Analyses of the PRF1 gene in individuals with hemophagocytic lymphohystiocytosis reveal the common haplotype R54C/A91V in Colombian unrelated families associated with late onset disease.

Isaura P Sánchez1, Lucía C Leal-Esteban, Jesús A Álvarez-Álvarez, Camilo A Pérez-Romero, Julio C Orrego, Malyive L Serna, Yadira Coll, Yolanda Caicedo, Edwin Pardo-Díaz, Jacques Zimmer, Jack J Bleesing, José L Franco, Claudia M Trujillo-Vargas.   

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL), is a rare autosomal recessive disorder characterized by an impairment of cytotoxic cells and uncontrolled activation of macrophages. This study presents the first description of four patients with FHL type 2 in Latin America. Patient 1 fulfilled the disease diagnostic criteria since 2 months of age, whereas patients 2, 3 and 4 exhibited the typical manifestations of the disease only later in their childhood. The PRF1 genetic analysis in these patients revealed two previously reported mutations: L17fsx50 and R54C. Interestingly, seven out of the 8 alleles evaluated here in patients carried the haplotype R54C/A91V, suggesting that this is a highly frequent FHL type 2 allele in Colombia. This haplotype confers residual cytotoxic function leading to late onset disease. Therefore, this report highlights the remarkable complexity of FHL diagnostic, emphasizing the importance of the genetic characterization of the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437823     DOI: 10.1007/s10875-012-9680-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  47 in total

1.  Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations.

Authors:  Rita Clementi; Lorenzo Emmi; Rita Maccario; Francesco Liotta; Lorenzo Moretta; Cesare Danesino; Maurizio Aricó
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

2.  Familial haemophagocytic reticulosis.

Authors:  J W FARQUHAR; A E CLAIREAUX
Journal:  Arch Dis Child       Date:  1952-12       Impact factor: 3.791

3.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 4.  Mechanisms of granule-dependent killing.

Authors:  S P Cullen; S J Martin
Journal:  Cell Death Differ       Date:  2007-11-02       Impact factor: 15.828

5.  Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity.

Authors:  Jérôme Feldmann; Gaël Ménasché; Isabelle Callebaut; Véronique Minard-Colin; Brigitte Bader-Meunier; Laurence Le Clainche; Alain Fischer; Françoise Le Deist; Marc Tardieu; Geneviève de Saint Basile
Journal:  Blood       Date:  2004-12-14       Impact factor: 22.113

6.  Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan.

Authors:  Naohiro Suga; Hidetoshi Takada; Akihiko Nomura; Shouichi Ohga; Eiichi Ishii; Kenji Ihara; Koichi Ohshima; Toshiro Hara
Journal:  Br J Haematol       Date:  2002-02       Impact factor: 6.998

Review 7.  Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis.

Authors:  Gael Ménasché; Jérôme Feldmann; Alain Fischer; Geneviève de Saint Basile
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

8.  Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations.

Authors:  Ikuyo Ueda; Yumi Kurokawa; Kenichi Koike; Shuichi Ito; Akifumi Sakata; Tsutomu Matsumora; Takashi Fukushima; Akira Morimoto; Eiichi Ishii; Shinsaku Imashuku
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

9.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

Authors:  Christina Trambas; Federico Gallo; Daniela Pende; Stefania Marcenaro; Lorenzo Moretta; Carmela De Fusco; Alessandra Santoro; Luigi Notarangelo; Maurizio Arico; Gillian M Griffiths
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

10.  Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.

Authors:  Yenan T Bryceson; Eva Rudd; Chengyun Zheng; Josefine Edner; Daoxin Ma; Stephanie M Wood; Anne Grete Bechensteen; Jaap J Boelens; Tiraje Celkan; Roula A Farah; Kjell Hultenby; Jacek Winiarski; Paul A Roche; Magnus Nordenskjöld; Jan-Inge Henter; Eric O Long; Hans-Gustaf Ljunggren
Journal:  Blood       Date:  2007-05-24       Impact factor: 22.113

View more
  4 in total

1.  A novel pathogenic variant in PRF1 associated with hemophagocytic lymphohistiocytosis.

Authors:  Camilo Andrés Pérez Romero; Isaura Pilar Sánchez; Sebastian Gutierrez-Hincapié; Jesús A Álvarez-Álvarez; Jaime Andres Pereañez; Rodrigo Ochoa; Carlos Enrique Muskus-López; Ruth G Eraso; Carolina Echeverry; Catalina Arango; José Luis Franco Restrepo; Claudia Milena Trujillo-Vargas
Journal:  J Clin Immunol       Date:  2015-05-15       Impact factor: 8.317

Review 2.  Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning.

Authors:  Elena Sieni; Valentina Cetica; Yvonne Hackmann; Maria Luisa Coniglio; Martina Da Ros; Benedetta Ciambotti; Daniela Pende; Gillian Griffiths; Maurizio Aricò
Journal:  Front Immunol       Date:  2014-04-16       Impact factor: 7.561

Review 3.  Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH.

Authors:  Samuel Cern Cher Chiang; Jack J Bleesing; Rebecca A Marsh
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

4.  Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset.

Authors:  Mathieu Amand; Gilles Iserentant; Aurélie Poli; Marwan Sleiman; Virginie Fievez; Isaura Pilar Sanchez; Nicolas Sauvageot; Tatiana Michel; Nasséra Aouali; Bassam Janji; Claudia Milena Trujillo-Vargas; Carole Seguin-Devaux; Jacques Zimmer
Journal:  Front Immunol       Date:  2017-06-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.